Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02105337 · ClinicalTrials.gov registry record

Tegaderm and Visual Evoked Potentials

A clinical trial, sponsored by Rutgers, The State University of New Jersey.

Terminated
Registry status
6
Enrollment target

NCT02105337: Clinical Trial study, sponsored by Rutgers, The State University of New Jersey.

NCT02105337 is a clinical trial that was terminated before completion, run by Rutgers, The State University of New Jersey. The registered enrollment target is 6 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02105337 was terminated before completion, sponsored by Rutgers, The State University of New Jersey.

TERMINATED
Registry status
6 participants
Enrollment target

Study Summary

The purpose of this study is to determine if a clear barrier placed over the eyes has any effect on goggle monitoring. When a patient has general anesthesia they lose the ability to blink and their eyes may dry. They may also lose the ability to keep their eyes fully closed. The anesthesiologist takes several steps to prevent injury to the eyes. First the eyes will be lubricated with ointment and the eyelids will be held in a closed position by the use of a clear barrier. During pituitary surgery it is the routine practice to perform many types of monitoring. One type of monitoring is to stimulate your eyes with a light. This helps your surgeon protect the nerve supply to your eyes. The light is supplied by a pair of goggles placed over your eyes during surgery. To help achieve our objective, the investigators are asking patients who are undergoing pituitary surgery to give us permission to record two sets of numbers form the monitoring device once prior to the application of the clear barrier and the second after the barrier is applied. This will be done when the patient is already asleep and will not be aware this is happening.

Primary Outcome

Visual evoked potential data in terms of latency and amplitude will be compared before and after tegaderm placement and statistically analyzed. We expect to make pilot preliminary conclusion if tegaderm application affects visual evoked potential monitoring in term of latency and amplitude of the data.

Trial Details

FieldValue
Enrollment Target 6 participants
Start Date 2013-07
Est. Completion 2014-09

Why NCT02105337 stopped before completion

NCT02105337 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 6 participants, a relatively small participant target.

The record links to 0 conditions, and to 0 interventions.

NCT02105337 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02105337 about?

NCT02105337 is a clinical study titled "Tegaderm and Visual Evoked Potentials". The purpose of this study is to determine if a clear barrier placed over the eyes has any effect on goggle monitoring. When a patient has general anesthesia they lose the ability to blink and their eyes may dry. They may also lose the ability to keep their eyes fully closed. The anesthesiologist tak...

What is the current status of trial NCT02105337?

This trial is currently terminated. The enrollment target is 6 participants. The study started on 2013-07. Estimated completion is 2014-09.

Who is sponsoring clinical trial NCT02105337?

This trial is sponsored by Rutgers, The State University of New Jersey, which has 413 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02105337, the US trial registry maintained by the National Library of Medicine. NCT02105337 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.